Akebia Therapeutics (AKBA) Other Non Operating Income (2013 - 2026)
Akebia Therapeutics' Other Non Operating Income came in at -$566,000 for Q2 2026, compared with $6.98 million a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Other Non Operating Income (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Akebia Therapeutics reported Other Non Operating Income of -$4.75 million; for FY2025, it came in at $3.1 million.
- Other Non Operating Income carries a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
- Going back by year, Other Non Operating Income was -$517,000 in FY2024, $887,000 in FY2023 (-71.8%), $3.15 million in FY2022 (+30.3%) and $2.41 million in FY2021 (+30.1%).
- The five-year range for quarterly Other Non Operating Income is -$2.33 million (Q2 2024) to $6.98 million (Q2 2025).
- The fastest year-over-year change in Other Non Operating Income over five years came in Q1 2022 (growth of 604.3%), and the weakest in Q1 2023 (a decline of 75.1%).
- Business Quant data shows AKBA's Other Non Operating Income at -$456,000 (Q1 2026), -$2.26 million (Q4 2025) and -$1.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -566,000.00 |
| Mar 31, 2026 | -456,000.00 |
| Dec 31, 2025 | -2.26 Mn |
| Sep 30, 2025 | -1.46 Mn |
| Jun 30, 2025 | 6.98 Mn |
| Mar 31, 2025 | 213,000.00 |
| Dec 31, 2024 | 828,000.00 |
| Sep 30, 2024 | 856,000.00 |
| Jun 30, 2024 | -2.33 Mn |
| Mar 31, 2024 | -517,000.00 |
| Dec 31, 2023 | 658,000.00 |
| Sep 30, 2023 | -43,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | 282,000.00 |
| Dec 31, 2022 | 434,000.00 |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 411,000.00 |
| Mar 31, 2022 | 1.13 Mn |
| Dec 31, 2021 | 560,000.00 |
| Sep 30, 2021 | 427,000.00 |
API Access
Akebia Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();